Lucira Health, Inc.·4

Feb 9, 7:55 PM ET

Susan Lior 4

4 · Lucira Health, Inc. · Filed Feb 9, 2021

Insider Transaction Report

Form 4
Period: 2021-02-09
Susan Lior
Director10% Owner
Transactions
  • Conversion

    Common Stock

    2021-02-09+877,4451,854,297 total(indirect: See footnote)
  • Conversion

    Common Stock

    2021-02-09$13.60/sh+473,729$6,442,7144,183,986 total(indirect: See footnote)
  • Conversion

    Common Stock

    2021-02-09+185,5122,039,809 total(indirect: See footnote)
  • Conversion

    Common Stock

    2021-02-09+976,852976,852 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock

    2021-02-09976,8520 total(indirect: See footnote)
    Common Stock (976,852 underlying)
  • Conversion

    Series C Preferred Stock

    2021-02-09185,5120 total(indirect: See footnote)
    Common Stock (185,512 underlying)
  • Conversion

    Series C Preferred Stock

    2021-02-093,710,2570 total(indirect: See footnote)
    Common Stock (3,710,257 underlying)
  • Conversion

    Common Stock

    2021-02-09+3,710,2573,710,257 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2021-02-09877,4450 total(indirect: See footnote)
    Common Stock (877,445 underlying)
  • Conversion

    Convertible Promissory Note

    2021-02-090 total(indirect: See footnote)
    Exercise: $13.60Exp: 2022-12-11Common Stock (473,729 underlying)
Footnotes (4)
  • [F1]Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.
  • [F2]The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
  • [F3]The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
  • [F4]The convertible promissory note automatically converted into shares of the Issuer's Common Stock at the closing of the IPO.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION